JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1676
World Kinect Corp
WKC
$1.83B
| $16.4M | ﹤0.01% |
582,438
+40,897
| +8% | +$1.23M |
2013 Q2
18 quarters
|
|
1677
Baytex Energy
BTE
$3.19B
| $16.4M | ﹤0.01% |
5,459,569
+2,288,197
| +72% | +$6.74M |
2013 Q2
18 quarters
|
|
|
NBIS
1678
CALL
Nebius Group N.V.
NBIS
$63.1B
| $16.4M | ﹤0.01% |
500,000
+340,000
| +213% | +$11.1M |
2017 Q3
1 quarter
|
|
1679
CALL
HP
HPQ
$29B
| $16.4M | ﹤0.01% |
779,300
+96,000
| +14% | +$2.04M |
2016 Q1
7 quarters
|
|
1680
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.6B
| $16.3M | ﹤0.01% |
312,492
+38,888
| +14% | +$2.04M |
2013 Q2
18 quarters
|
|
1681
PUT
Crown Castle
CCI
$28.1B
| $16.3M | ﹤0.01% |
146,700
| – | – |
2016 Q4
4 quarters
|
|
1682
iShares US Oil & Gas Exploration & Production ETF
IEO
$757M
| $16.3M | ﹤0.01% |
250,565
-1,076
| -0.4% | -$65K |
2013 Q2
18 quarters
|
|
1683
Group 1 Automotive
GPI
$3.06B
| $16.3M | ﹤0.01% |
229,182
+104,934
| +84% | +$7.99M |
2013 Q2
18 quarters
|
|
|
GLOP
1684
DELISTED
GASLOG PARTNERS LP
GLOP
| $16.2M | ﹤0.01% |
655,650
+74,602
| +13% | +$1.73M |
2015 Q4
8 quarters
|
|
|
CVG
1685
DELISTED
Convergys
CVG
| $16.2M | ﹤0.01% |
688,762
+275,166
| +67% | +$6.79M |
2013 Q2
18 quarters
|
|
1686
The Greenbrier Companies
GBX
$1.24B
| $16.2M | ﹤0.01% |
303,405
+12,389
| +4% | +$622K |
2014 Q3
13 quarters
|
|
|
DNKN
1687
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $16.2M | ﹤0.01% |
+250,800
| New | +$14.6M |
2017 Q4
0 quarters
|
|
1688
PUT
HCA Healthcare
HCA
$91.7B
| $16.2M | ﹤0.01% |
183,900
| – | – |
2017 Q2
2 quarters
|
|
1689
CALL
Merck
MRK
$355B
| $16.1M | ﹤0.01% |
300,042
+151,750
| +102% | +$8.41M |
2014 Q3
13 quarters
|
|
1690
PUT
Humana
HUM
$45.6B
| $16.1M | ﹤0.01% |
64,800
+23,800
| +58% | +$5.88M |
2017 Q3
1 quarter
|
|
1691
PUT
Transocean
RIG
$5.85B
| $16M | ﹤0.01% |
1,500,000
-500,000
| -25% | -$5.19M |
2014 Q3
13 quarters
|
|
|
TIVO
1692
DELISTED
Tivo Inc
TIVO
| $16M | ﹤0.01% |
1,026,265
-1,549,415
| -60% | -$26.8M |
2013 Q2
18 quarters
|
|
1693
Revvity
RVTY
$16.6B
| $16M | ﹤0.01% |
218,904
+49,630
| +29% | +$3.56M |
2013 Q2
18 quarters
|
|
|
AAT
1694
American Assets Trust
AAT
$1.31B
| $16M | ﹤0.01% |
417,712
+144,089
| +53% | +$5.67M |
2013 Q2
18 quarters
|
|
|
B
1695
CALL
Barrick Mining
B
$66B
| $16M | ﹤0.01% |
1,103,900
+570,000
| +107% | +$8.4M |
2014 Q4
12 quarters
|
|
|
SF
1696
Stifel
SF
$10.6B
| $15.9M | ﹤0.01% |
601,218
+76,455
| +15% | +$1.87M |
2013 Q2
18 quarters
|
|
|
SNBR
1697
DELISTED
Sleep Number
SNBR
| $15.9M | ﹤0.01% |
423,155
-108,139
| -20% | -$3.68M |
2014 Q3
13 quarters
|
|
1698
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.16B
| $15.9M | ﹤0.01% |
135,999
+16,570
| +14% | +$1.91M |
2015 Q4
8 quarters
|
|
1699
Ormat Technologies
ORA
$5.51B
| $15.9M | ﹤0.01% |
248,381
-17,481
| -7% | -$1.11M |
2014 Q4
12 quarters
|
|
|
COHR
1700
DELISTED
Coherent Inc
COHR
| $15.8M | ﹤0.01% |
56,156
+11,344
| +25% | +$3.16M |
2013 Q2
18 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.